每經AI快訊，泓博醫(yi)藥（SZ 301230，收盤價：30.88元）5月(yue)6日晚間發布(bu)公(gong)(gong)告稱，截(jie)至本(ben)(ben)公(gong)(gong)告披(pi)露日，沈(shen)陽富邦投資有限責任公(gong)(gong)司持有上海泓博智源醫(yi)藥股(gu)(gu)份(fen)有限公(gong)(gong)司約866萬股(gu)(gu)，占公(gong)(gong)司扣除(chu)最新披(pi)露的回(hui)購專(zhuan)戶股(gu)(gu)份(fen)后(hou)總股(gu)(gu)本(ben)(ben)比例(li)為6.3%。沈(shen)陽富邦計(ji)劃在本(ben)(ben)公(gong)(gong)告發布(bu)之日起15個交易日后(hou)的3個月(yue)內以(yi)集中(zhong)競價或大(da)宗交易方式(shi)減持公(gong)(gong)司股(gu)(gu)份(fen)不超過137萬股(gu)(gu)，即減持比例(li)不超過公(gong)(gong)司扣除(chu)最新披(pi)露的回(hui)購專(zhuan)戶股(gu)(gu)份(fen)后(hou)總股(gu)(gu)本(ben)(ben)的1%。

截至發(fa)稿，泓(hong)博醫藥市值為43億元(yuan)。

每經(jing)頭條（nbdtoutiao）——

(記者 曾健輝)

免責聲明：本(ben)文(wen)內容與數(shu)據(ju)(ju)僅供(gong)參(can)考(kao)，不構成投(tou)資(zi)建議，使(shi)用(yong)前(qian)請(qing)核實(shi)。據(ju)(ju)此操作，風險自擔。